WO2019004969A3 - Use of a vegetal formulation containing pomegranate seed oil as an assistive agent in reduction of blood lipids known as triglyceride - Google Patents

Use of a vegetal formulation containing pomegranate seed oil as an assistive agent in reduction of blood lipids known as triglyceride Download PDF

Info

Publication number
WO2019004969A3
WO2019004969A3 PCT/TR2018/050158 TR2018050158W WO2019004969A3 WO 2019004969 A3 WO2019004969 A3 WO 2019004969A3 TR 2018050158 W TR2018050158 W TR 2018050158W WO 2019004969 A3 WO2019004969 A3 WO 2019004969A3
Authority
WO
WIPO (PCT)
Prior art keywords
seed oil
vegetal
triglyceride
pomegranate seed
reduction
Prior art date
Application number
PCT/TR2018/050158
Other languages
French (fr)
Other versions
WO2019004969A2 (en
WO2019004969A9 (en
Inventor
Mevlüt Büyükhelvacigi̇l
Original Assignee
Helvacizade Gida İlaç Ki̇mya Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helvacizade Gida İlaç Ki̇mya Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ filed Critical Helvacizade Gida İlaç Ki̇mya Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇
Publication of WO2019004969A2 publication Critical patent/WO2019004969A2/en
Publication of WO2019004969A3 publication Critical patent/WO2019004969A3/en
Publication of WO2019004969A9 publication Critical patent/WO2019004969A9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the use of a vegetal formulation in the pharmaceutical industry prepared in capsule form by using pomegranate seed oil rich in essential fatty acids such as punicic acid (Omega 5) as an assistive agent in reduction of blood lipids known as triglyceride and whose formulation comprises pomegranate seed oil, dl a-tocopherol, dl a- tocopheryl acetate, glycerine, purified water and gelatin that procures the integrity of the content and the capsulated formation.
PCT/TR2018/050158 2017-04-19 2018-04-10 Use of a vegetal formulation containing pomegranate seed oil as an assistive agent in reduction of blood lipids known as triglyceride WO2019004969A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2017/05831 2017-04-19
TR2017/05831A TR201705831A2 (en) 2017-04-19 2017-04-19 THE USE OF A VEGETABLE FORMULATION CONTAINING POMEGRANOUS SEED OIL TO REDUCE BLOOD FATS KNOWN AS TRIGLYCERITE

Publications (3)

Publication Number Publication Date
WO2019004969A2 WO2019004969A2 (en) 2019-01-03
WO2019004969A3 true WO2019004969A3 (en) 2019-04-11
WO2019004969A9 WO2019004969A9 (en) 2019-05-09

Family

ID=64742573

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2018/050158 WO2019004969A2 (en) 2017-04-19 2018-04-10 Use of a vegetal formulation containing pomegranate seed oil as an assistive agent in reduction of blood lipids known as triglyceride

Country Status (2)

Country Link
TR (1) TR201705831A2 (en)
WO (1) WO2019004969A2 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641850B1 (en) * 1999-04-19 2003-11-04 Stewart And Lynda Resnick Revocable Trust Methods of using pomegranate extracts for causing regression in lesions due to arteriosclerosis in humans
US20070104730A1 (en) * 2005-11-10 2007-05-10 Jarrow Formulas Methods and compositions employing pomegranate extracts and fementation products of statin-producing fungi
TW201225986A (en) * 2010-12-17 2012-07-01 Tci Co Ltd Raw material extract used for antioxidation
CN103891924A (en) * 2014-04-21 2014-07-02 山东三星玉米产业科技有限公司 Blending oil containing corn oil and preparation method of blending oil
US9205117B1 (en) * 2007-02-07 2015-12-08 Pom Wonderful, Llc Pomegranate seed oil composition
CN105726589A (en) * 2016-03-08 2016-07-06 新疆维吾尔药业有限责任公司 Application of pomegranate and sour pomegranate medicine composition to preparation of drug for treating hyperlipidaemia

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641850B1 (en) * 1999-04-19 2003-11-04 Stewart And Lynda Resnick Revocable Trust Methods of using pomegranate extracts for causing regression in lesions due to arteriosclerosis in humans
US20070104730A1 (en) * 2005-11-10 2007-05-10 Jarrow Formulas Methods and compositions employing pomegranate extracts and fementation products of statin-producing fungi
US9205117B1 (en) * 2007-02-07 2015-12-08 Pom Wonderful, Llc Pomegranate seed oil composition
TW201225986A (en) * 2010-12-17 2012-07-01 Tci Co Ltd Raw material extract used for antioxidation
CN103891924A (en) * 2014-04-21 2014-07-02 山东三星玉米产业科技有限公司 Blending oil containing corn oil and preparation method of blending oil
CN105726589A (en) * 2016-03-08 2016-07-06 新疆维吾尔药业有限责任公司 Application of pomegranate and sour pomegranate medicine composition to preparation of drug for treating hyperlipidaemia

Also Published As

Publication number Publication date
WO2019004969A2 (en) 2019-01-03
WO2019004969A9 (en) 2019-05-09
TR201705831A2 (en) 2017-07-21

Similar Documents

Publication Publication Date Title
US20150004226A1 (en) Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof
ES2680913T3 (en) Oral veterinary pharmaceutical and nutraceutical compositions
AU2014359194A1 (en) Lipid microcapsules preferably comprising a retinoid, and composition containing same, method for the production thereof, and use thereof in dermatology
RU2014139008A (en) HORMONE-CONTAINING EMULSION CONTAINING KRILL PHOSPHOLIPIDS
JP2016519571A5 (en)
JP2013510095A (en) Nutritional supplements to reduce dry eye
RU2017129161A (en) LIPID COMPOSITIONS
ES2889874T3 (en) Treatment of optic neuropathy and reduction of steroid-induced oxidative stress with stabilized polyunsaturated substances
RU2014119376A (en) NEW COATING SYSTEM
WO2016040570A3 (en) Dietary emulsion formulations and methods for using the same
CN107530358B (en) Gel capsules containing sterols and solubilizing agents
NO20084478L (en) Conjugated Lipid Derivatives
RU2020101477A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DGLK AND THEIR APPLICATION
JP6367399B2 (en) Polyunsaturated fatty acid-containing composition
RU2323713C2 (en) Cosmetic and/or dermatological composition
WO2019004969A3 (en) Use of a vegetal formulation containing pomegranate seed oil as an assistive agent in reduction of blood lipids known as triglyceride
WO2012075093A3 (en) Topical formulations for administration of omega-3 fatty acids
PE20220942A1 (en) COMPOSITION OF A SMALL-MOLECULE PI4KIIIalpha INHIBITOR, METHOD OF PREPARATION AND APPLICATION OF THE SAME
TWI633896B (en) Artificial sebum film and manufacturing method thereof
WO2019004968A3 (en) Use of a vegetal formulation containing pomegranate seed oil as an immune system enhancer due to its antioxidant function
EA201692398A1 (en) HOMOGENE COMPOSITION FOR ORAL ADMINISTRATION, CONTAINING OMEGA-3 POLYINSATURATED FATTY ACIDS AND RESVERATROL
AR070405A1 (en) COMPOSITIONS FOR THE PREVENTION AND / OR TREATMENT OF MACULAR DEGENERATION AND / OR LOSS OF VISUAL ACUTE
CN108368451A (en) The oxidizing and depressing method of fat or oil composition and grease
WO2018222164A3 (en) Use of an herbal formula containing pumpkin seed oil in bph treatment
AR097148A1 (en) FOOD COMPOSITION FOR RUMINANTS AND METHOD TO PREPARE IT

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18822689

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18822689

Country of ref document: EP

Kind code of ref document: A2